South Korea Gastrointestinal Diseases Drug Development Market (2025-2031) | Industry, Growth, Share, Competitive Landscape, Outlook, Companies, Forecast, Trends, Size & Revenue, Value, Segmentation, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Gastrointestinal Diseases Drug Development Market - Industry Life Cycle

3.4 South Korea Gastrointestinal Diseases Drug Development Market - Porter's Five Forces

3.5 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Molecular Targets, 2021 & 2031F

3.7 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Marketed Drugs, 2021 & 2031F

3.8 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Clinical Trials, 2021 & 2031F

3.9 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.10 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of gastrointestinal diseases in South Korea

4.2.2 Growing awareness and focus on healthcare in the country

4.2.3 Rise in research and development activities in the pharmaceutical sector

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug development

4.3.2 High costs associated with drug development and clinical trials

6.1 South Korea Gastrointestinal Diseases Drug Development Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Gastroenteritis, 2021- 2031F

6.1.4 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Inflammatory Bowel Disease (IBD), 2021- 2031F

6.1.5 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F

6.1.6 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F

6.2 South Korea Gastrointestinal Diseases Drug Development Market, By Molecular Targets

6.2.1 Overview and Analysis

6.2.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Sodium Transporter NHE3 Inhibitor, 2021- 2031F

6.2.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Sphinogosine-1-Phosphate Receptor Functional Antagonist, 2021- 2031F

6.2.4 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Tumor Necrosis Factor (TNF) Blocker, 2021- 2031F

6.2.5 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F

6.3 South Korea Gastrointestinal Diseases Drug Development Market, By Marketed Drugs

6.3.1 Overview and Analysis

6.3.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Infliximab, 2021- 2031F

6.3.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Adalimumab, 2021- 2031F

6.3.4 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Mesalazine, 2021- 2031F

6.3.5 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F

6.4 South Korea Gastrointestinal Diseases Drug Development Market, By Clinical Trials

6.4.1 Overview and Analysis

6.4.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Etrolizumab, 2021- 2031F

6.4.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By SHP647, 2021- 2031F

6.4.4 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By ABX464, 2021- 2031F

6.4.5 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By ASP3291, 2021- 2031F

6.4.6 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Others, 2021- 2031F

6.5 South Korea Gastrointestinal Diseases Drug Development Market, By Route of Administration

6.5.1 Overview and Analysis

6.5.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Oral, 2021- 2031F

6.5.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Injectable, 2021- 2031F

6.6 South Korea Gastrointestinal Diseases Drug Development Market, By End-Users

6.6.1 Overview and Analysis

6.6.2 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Hospitals, 2021- 2031F

6.6.3 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Homecare, 2021- 2031F

6.6.4 South Korea Gastrointestinal Diseases Drug Development Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

7.1 South Korea Gastrointestinal Diseases Drug Development Market Export to Major Countries

7.2 South Korea Gastrointestinal Diseases Drug Development Market Imports from Major Countries

8.1 Number of clinical trials for gastrointestinal drugs conducted in South Korea

8.2 Investment in research and development for gastrointestinal diseases drug development

8.3 Number of new drug approvals for gastrointestinal diseases in South Korea

9.1 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Molecular Targets, 2021 & 2031F

9.3 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Marketed Drugs, 2021 & 2031F

9.4 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Clinical Trials, 2021 & 2031F

9.5 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.6 South Korea Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By End-Users, 2021 & 2031F

10.1 South Korea Gastrointestinal Diseases Drug Development Market Revenue Share, By Companies, 2024

10.2 South Korea Gastrointestinal Diseases Drug Development Market Competitive Benchmarking, By Operating and Technical Parameters